It was decided that this patient should have her ECT performed in the main operating suite and this would occur every second day. She underwent a total of ten general anaesthetics for ECT, the technique used for each ECT being intravenous induction with thiopentone, muscle relaxation with alcuronium 15 mg and controlled ventilation with nitrous oxide, oxygen and isoflurane. Patient monitoring comprised electrocardiograph, Dinamap (TM) Criticon (automatic blood pressure recorder) and neuromuscular function monitor with train of four. ECT was administered once the fourth twitch was lost and neostigmine/atropine given when the fourth twitch had returned. Presence or absence of twitch was determined by palpation of adductor pollicis muscle. During the first two anaesthetics, an intra-arterial cannula was placed in the radial artery for direct monitoring of arterial blood pressure and for collection of blood for serial serum potassium levels.
Serial serum potassium concentrations at the following times, prior to induction, prior to ECT, and at 1, 2, 3, 5 and 10 minutes following ECT for the first two treatments are shown in Table 1 . The ECT resulted in fits, attenuated so that the tonic phase was easily visible and the subsequent clonic phase was limited to neck movement. By completion of the tenth ECT, the patient's psychiatric state showed marked improvement and ECT was ceased, DISCUSSION Our survey of the literature revealed no reference to the use of ECT in patients suffering from burns. However, several studies looked at potassium levels during ECT in otherwise normal patients.
Haw' compared mean serum potassium rises in patients undergoing ECT under thiopentone/ suxamethonium with those in patients receiving methohexitone/suxamethonium. She found no dangerous rises in mean serum potassium during ECT, but the rises were less with thiopentone, compared with methohexitone, which she concluded conferred some protective effect in this regard.
Pilditch and Baker 2 studied the effects on mean plasma potassium rises of four different induction agent/relaxant regimes during ECT. They found a significant rise in mean plasma potassium compared with pre-induction levels in three of the four regimens (approximately 0.3 mmolll at 3 minutes) but only methohexitone/suxamethonium produced a rise in mean plasma potassium which was significantly different from controls (0.5 mmolll at 15 minutes).
BalP studied the effect on mean plasma potassium levels in patients undergoing ECT with three different induction agent/relaxant regimems and compared these with a control group having anaesthesia for other procedures. They found a rise in mean plasma potassium of 0.4 mmolll in patients undergoing ECT, the rise occurring one minute after suxamethonium fasciculations (half minute post convulsion) and this was greater and fell more rapidly than the serum potassium in patients anaesthetised for other procedures. They concluded that this was due to the 'synchronous contraction of muscles containing blood with an increased potassium concentration following suxamethonium' .
McCleave and Blakemore 4 reported on 3500 anaesthetics given for ECT. In 50 of these, all of whom received thiopentone and suxamethonium 30-40 mg, they measured the serum potassium before induction, after the convulsion, and 15 minutes later. They found a slight but not significant rise in mean plasma potassium.
Finally, Marks 5 reviewed the physiological and anaesthetic considerations of ECT. Among the many unwanted side-effects of suxamethonium he lists the rise in serum potassium and suggests the use of a nondepolarising muscle relaxant in situations where this rise might be dangerous.
Thus it would seem from these papers that ECT under thiopentone and suxamethonium anaesthesia produces a slight rise in plasma potassium even in normal people, although this rise is not significantly different from that seen after thiopentone and suxamethonium without ECT.
The protective effect of thiopentone is also noted. We know that suxamethonium causes a dangerous rise of serum potassium in postburns patients, and we would assume that an unmodified fit could also cause a dangerous release of potassium from cells. No one has yet documented a rise in serum potassium resulting from the administration of ECT in a patient who had received a non-depolarising muscle relaxant for the procedure.
Our technique therefore was to use thiopentone as induction agent, alcuronium for muscle relaxation and to monitor the block, and nitrous oxide and isoflurane to prevent awareness until the block was capable of being reversed safely. Isoflurane was chosen because of its low rate of metabolism and because of the need for repeated anaesthetics.
Hyperkalaemia was not found to accompany the fit, and the technique described was thought to be safe and reasonable in these patients. It has not been shown that the ECT -induced convulsion could not result in a hyperkalaemic response in burns patients. The patient had 20070 body surface area of partial thickness burn two months previously and the fits were 
